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In the mouse hypothalamus, ciliary neurotrophic factor (CNTF) is mainly expressed by
ependymal cells and tanycytes of the ependymal layer covering the third ventricle. Since
exogenously administered CNTF causes reduced food intake and weight loss, we tested
whether endogenous CNTF might be involved in energy balance regulation. We thus
evaluated CNTF production and responsiveness in the hypothalamus of mice fed a high-fat
diet (HFD), of ob/ob obese mice, and of mice fed a calorie restriction (CR) regimen. RT-PCR
showed that CNTF mRNA increased significantly in HFD mice and decreased significantly
in CR animals. Western blotting confirmed that CNTF expression was higher in HFD mice
and reduced in CR mice, but high interindividual variability blunted the significance of
these differences. By immunohistochemistry, hypothalamic tuberal and mammillary region
tanycytes stained strongly for CNTF in HFD mice, whereas CR mice exhibited markedly
reduced staining. RT-PCR andWestern blotting disclosed that changes in CNTF expression
were paralleled by changes in the expression of its specific receptor, CNTF receptor α
(CNTFRα). Injection of recombinant CNTF and detection of phospho-signal transducer and
activator of transcription 3 (P-STAT3) showed that CNTF responsiveness by the ependymal
layer, mainly by tanycytes, was higher in HFD than CR mice. In addition, in HFD mice
CNTF administration induced distinctive STAT3 signaling in a large neuron population
located in the dorsomedial and ventromedial nuclei, perifornical area and mammillary body.
The hypothalamic expression of CNTF and CNTFRα did not change in the hyperphagic,
leptin-deficient ob/ob obese mice; accordingly, P-STAT3 immunoreactivity in CNTF-treated
ob/ob mice was confined to ependymal layer and arcuate neurons. Collectively, these
data suggest that hypothalamic CNTF is involved in controlling the energy balance and
that CNTF signaling plays a role in HFD obese mice at specific sites.
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INTRODUCTION
Ciliary neurotrophic factor (CNTF) is a 22 kDa cytokine
belonging to the interleukin (IL)-6 family, a group of struc-
turally related cytokines that also include IL-11, oncostatin M,
leukemia inhibitory factor (LIF), cardiotrophin-1, cardiotrophin-
like cytokine and, more recently, neuropoietin (Bauer et al.,
2007). CNTF is produced by glial cells in the nervous tissue;
its expression is strongest in peripheral nerve Schwann cells
(Friedman et al., 1992; Rende et al., 1992) and cerebral white mat-
ter astrocytes (Stockli et al., 1991; Guthrie et al., 1997; Dallner
et al., 2002). Numerous studies have documented the ability of
CNTF to promote cell survival and differentiation in a number
of neuronal and glial cell types (Sendtner et al., 1994; Sleeman
et al., 2000). Binding of CNTF to a three-part receptor com-
plex (CNTFR) consisting of the ligand-specific binding subunit
receptor α (CNTFRα), signal-transducing subunit gp130, and
LIF receptor β (Davis et al., 1993; Ip et al., 1993) activates the
Janus family of tyrosine kinases (Jak1/Jak2), thereby leading to
tyrosine phosphorylation, dimerization and nuclear transloca-
tion of signal transducers and activators of transcription (STATs),
principally STAT3 (Heinrich et al., 2003; Simi and Ibanez, 2010).
In the peripheral nervous system, CNTF produced by Schwann
cells is essential for the postnatal maintenance of motor neu-
rons (Holtmann et al., 2005). Indeed, ablation of the mouse
CNTF gene by homologous recombination leads to a progres-
sive atrophy and loss of motor neurons that is more significant
in older animals (Masu et al., 1993). In addition, CNTF protects
axons in progressive motor neuronopathy mutant mice (Sendtner
et al., 1992) and in experimental autoimmune encephalomyelitis
(Linker et al., 2002). Therapeutic trials where patients with the
motor neuron disease amyotrophic lateral sclerosis were treated
with human recombinant CNTF (ACTS, 1996; Miller et al., 1996)
failed to provide satisfactory effects on motor performances and
were associated with significant side effects, including anorexia
and weight loss. Subsequent studies also using Axokine, a modi-
fied form of human CNTF with improved potency and stability,
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confirmed that CNTF administration to humans and experimen-
tal animals results in decreased food intake, weight loss, and an
improvement of obesity-associated hyperglycaemia, hyperinsuli-
naemia, and dyslipidaemia (Gloaguen et al., 1997; Lambert et al.,
2001; Sleeman et al., 2003; Blüher et al., 2004).
Studies aimed at elucidating themechanism of action of exoge-
nously administered CNTF or Axokine stressed the role(s) of
CNTF in the hypothalamus, the key region for energy balance
regulation and homeostasis. It was suggested that the anorec-
tic response to CNTF could be due to a leptin-like action in
the hypothalamus via activation of Jak1/Jak2-STAT3 signaling
in arcuate nucleus neurons (Lambert et al., 2001; Janoschek
et al., 2006) and/or to production of novel neurons capable of
integration in the leptin-dependent neuronal circuits regulat-
ing the energy balance (Kokoeva et al., 2005). Recently however,
CNTFRα deletion in hypothalamic leptin receptor-expressing
neurons failed to impair the anorectic effect of Axokine (Stefater
et al., 2012). Thus, CNTF may also act on hypothalamic targets
other than those affected by leptin.
In a recent paper (Severi et al., 2012), we showed that CNTF is
constitutively expressed by glial cells in the mouse hypothalamus.
In normal mice CNTF was detected by immunohistochemistry
in the ependymal layer throughout the rostro-caudal extension
of the third ventricle in numerous tanycytes and multiciliated
ependymal cells. Some astrocytes, mainly located in a subependy-
mal position, were also CNTF-positive. In addition, treatment
with recombinant CNTF and detection of phospho-STAT3 (P-
STAT3) immunoreactivity showed that multiciliated ependymal
cells and tanycytes producing CNTF are also CNTF-responsive. A
distinctive pattern was seen in the tuberal region of the mouse
hypothalamus, where numerous CNTF-producing cells were
adjacent to and overlapped to a considerable extent with CNTF-
responsive ependymal cells. To assess whether endogenously-
produced CNTF has a role in the pathophysiological control of
the energy balance, here we set out to evaluate whether hypotha-
lamic CNTF signaling is affected by different energy balance chal-
lenges. In particular, we examined the expression of CNTF and
CNTFRα, and the distribution of CNTF-producing and CNTF-
responsive cells in the hypothalamus of mice rendered obese by
a high-fat diet (HFD) or by leptin-deficiency (ob/ob mice), and
in mice fed a calorie restriction (CR) diet. Collectively, our find-
ings suggest that HFD obesity is associated with an increase in
hypothalamic CNTF signaling, whereas CR induces a reduction
of CNTF signaling in the hypothalamus. In contrast to HFD, the
hyperphagic obesity of ob/obmice did not appear to be associated
with modifications in CNTF signaling.
MATERIALS AND METHODS
ANIMALS AND EXPERIMENTAL CONDITIONS
Four-week-old male Swiss CD-1 mice purchased from Charles
River (Calco, Italy) were housed individually in plastic cages
under constant environmental conditions (12 h light/dark cycle at
22◦C) with ad libitum access to food and water. Handling was lim-
ited to cage cleaning. After one week of acclimatization, animals
were weighed and divided into three groups with approximately
equal mean body weight: one group was fed an HFD (Charles
River; 50 kJ% from fat, 30 kJ% from carbohydrates and 20 kJ%
from proteins; HFD mice); another group was fed a low-fat diet
(Charles River; 19 kJ% from fat, 50 kJ% from carbohydrates and
31 kJ% from proteins; control mice), and the third group was
fed about 60% of the normal daily amount of the low-fat food
normalized for weight and age (CR mice). CR mice were fed
from 7.00 to 8.00 am, whereas HFD and control mice had ad
libitum access to their food. These feeding conditions were main-
tained for 12 weeks. Male C57BL/6 wild type, C57BL/6-Lep◦b
ob/+ and C57BL/6-Lep◦b ob/ob mice purchased from Charles
River at 4 weeks of age were housed individually and kept under
constant environmental conditions with free access to standard
chow diet and water. They were used for experimental proce-
dures at 12–14 weeks of age. All animals were sacrificed in a fed
state between 11.00 and 12.00 am. All efforts were made to mini-
mize animal suffering and to reduce the number of animals used.
Experiments were carried out in accordance with EC Council
Directive 86/609/EEC of 24 November 1986.
For RT-PCR and Western blot assays animals were decapi-
tated, the brain was rapidly removed from the skull, placed with
its ventral side up in a pre-cooled adult mouse coronal brain
matrix (ASI Instruments, Warren, MI, USA) and the hypothala-
mus was dissected out. Histological examination confirmed that
these specimens consisted of all parts of the hypothalamus—from
the preoptic area to the mammillary body—including the whole
third ventricle. The remaining part of the brain was also collected
as a whole. Specimens were immediately snap-frozen in liquid
nitrogen and stored at −80◦C. For morphological studies, ani-
mals were anaesthetized with 100mg/kg ketamine (Ketavet, Farm.
Gellini, Aprilia, Italy) in combination with 10mg/kg xylazine
(Rompum, Bayer AG, Leverkusen, Germany) and perfused tran-
scardially with 4% paraformaldehyde in 0.1M phosphate buffer
(PB), pH 7.4. Brains were carefully removed from the skull, post-
fixed with the same fixative solution for 24 h at 4◦C and washed
in PB. Free-floating coronal sections (40-μm-thick) of the entire
brain from the septum to the mammillary body of the hypotha-
lamus were obtained with a Leica VT1200S vibratome (Leica
Microsystems, Vienna, Austria) and kept in phosphate buffered
saline (PBS), pH 7.4, at 4◦C until use.
Before sacrifice, some mice received a single intraperitoneal
injection (0.3mg/kg of body weight) of recombinant rat CNTF
(R&D Systems, Minneapolis, MN, USA) or pyrogen-free saline
using a Hamilton syringe. The volumes of CNTF, or vehicle,
ranged from 180 to 360μl according to body weight. Forty-
five minutes later mice were anaesthetized and processed for
morphological analyses as described above.
REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (RT-PCR)
Total RNA was extracted from samples after homogenization
using TRIZOL reagent (Invitrogen, Milano, Italy), purified,
digested with ribonuclease-free deoxyribonuclease and concen-
trated using RNeasy Micro kit (Qiagen, Milano, Italy) according
to the respective manufacturer’s instructions.
For determination of mRNA levels, 1μg of RNA was
reverse-transcribed with a High-Capacity cDNA RT Kit with
RNase Inhibitor (Applied BioSystems, Foster City, CA, USA)
in a total volume of 20μl. Real time gene expression was
analyzed in triplicate by using TaqMan Gene Expression Assays
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(Applied BioSystems) as listed: TATA box binding protein
(TBP): Mm00446973_m1; CNTF: Mm00446373_m1; CNTFRα:
Mm00516693_m1; neuropeptide Y (NPY): Mm03048253_m1;
proopiomelanocortin (POMC): Mm00435874_m1 and Master
Mix TaqMan (Applied BioSystems).
Reactions were carried out in an ABI 7300 system (Applied
Biosystems) using 50 ng of RNA in a final reaction volume of
20μl and the following thermal cycle protocol: initial incuba-
tion at 95◦C −10min, followed by 40 cycles of 95◦C −15 s
and 60◦C −20 s. In order to rule out genomic contamination,
a control reaction where reverse transcriptase was omitted in
the amplification mixture was included for each sample. Relative
mRNA expression was determined by the -Ct method using
TBP levels as an endogenous control. Differences in starting total
RNA and in cDNA synthesis efficiency among samples were nor-
malized using TBP expression. Results were expressed as fold
changes in relative gene expression compared with the control
group. Data are presented as histograms ± standard error of the
mean (SEM).
PRIMARY ANTIBODIES
The following primary antibodies were used in the study:
anti-CNTF polyclonal goat serum (R&D Systems, cat # AF-
557-NA); anti-CNTF polyclonal rabbit serum (cat # ab46172);
anti-CNTFRα polyclonal rabbit serum (both from Abcam,
Cambridge, UK, cat # ab127425); anti-glial fibrillary acidic pro-
tein (GFAP) monoclonal mouse antibody (Sigma, St Louis, MO,
USA, cat # G3893); anti-phospho-specific-(Tyr705)-STAT3 poly-
clonal rabbit serum (Cell Signaling Technology Inc., Beverly, MA,
USA, cat # 9131); anti-β-tubulin monoclonal mouse antibody
(Pierce, Rockford, IL,USA, cat # MA5-16308); anti-HuC/D mon-
oclonalmouse antibody (Molecular Probes, Eugene, OR, USA, cat
# A21271).
WESTERN BLOT ANALYSIS
Proteins were isolated from the phenol-ethanol supernatant
obtained using TRIZOL reagent according to the manufacturer’s
instructions. Soluble protein was quantified using a Bradford pro-
tein assay (Bio-Rad, Richmond, CA, USA) and equal amounts
of proteins were loaded onto 12-well Bolt® 4–12% Bis-Tris Plus
Gels (Invitrogen) and resolved by SDS–PAGE. Proteins were
transferred to 0.2mm nitrocellulose membranes using iBlot®
System EU (Invitrogen) according to the manufacturer’s instruc-
tions. After blocking the membrane with 5% non-fat dry milk
(Bio-Rad) in Tris-buffered saline with 0.1% Tween 20 (TBS-T),
membranes were incubated overnight at 4◦C with the primary
antibodies: polyclonal rabbit anti-CNTF (diluted 1:1500), poly-
clonal rabbit anti-CNTFRα (diluted 1:500) or monoclonal mouse
anti-β-tubulin (diluted 1:3000). Membranes were extensively
washed with TBS-T 0.1% and then incubated for 2 h with the
secondary antibodies: horseradish peroxidase-conjugated goat
anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA;
diluted 1:1000; CNTF and CNTFRα schedules) or horseradish
peroxidase-conjugated goat anti-mouse IgG (Bethyl Laboratories,
Montgomery, TX, USA; diluted 1:20,000; β-tubulin schedule).
Specific immunoreactivity was visualized using Super Signal West
Pico chemiluminescent substrate (Pierce). Protein levels were
assessed in at least three separate experiments per molecule by
densitometric analysis using Chemidoc and Quantity-One pro-
gram (Bio-Rad). Quantities were normalized to β-tubulin expres-
sion. Results were expressed as fold changes in relative protein
expression compared with the control group. Data are shown as
histograms ± SEM.
PEROXIDASE IMMUNOHISTOCHEMISTRY
Immunohistochemical detection of CNTF was performed
according to standard procedures. In brief, free-floating sec-
tions were reacted with 0.3% H2O2 (in PBS; 30min) to block
endogenous peroxidase, rinsed with PBS and incubated with 3%
normal serum blocking solution (in PBS; 60min). Then they
were incubated with the anti-CNTF polyclonal goat serum (dilu-
tion 1:100) in PBS, overnight at 4◦C. After a thorough rinse in
PBS, sections were incubated in 1:200 v/v biotinylated secondary
antibody solution (in PBS; 30min), rinsed in PBS and incu-
bated in avidin-biotin peroxidase complex (ABC Elite PK6100,
Vector), washed several times in PBS and finally incubated in
3,3′ diaminobenzidine tetrahydrochloride (0.05% in 0.05M Tris
with 0.03% H2O2; 5min). After immunohistochemical stain-
ing, sections were mounted on slides, air-dried, dehydrated in
ethanol, cleared with xylene and covered with Entellan. The
ability of this antibody specifically to detect CNTF in mouse
brain has previously been shown by our group (Severi et al.,
2012).
Unmasking procedures were used for P-STAT3 immunohisto-
chemical detection (Frontini et al., 2008). Free-floating sections
were reacted with 1% NaOH and 1% H2O2 (20min), 0.3%
glycine (10min) and 0.03% sodium dodecyl sulfate (10min).
After rinsing in PBS, they were blocked with 3% normal goat
serum (in 0.2% Triton X-100; 60min) and incubated with poly-
clonal anti-P-STAT3 rabbit serum (dilution 1:1000) in PBS,
overnight at 4◦C. The next day, the procedure was performed
as described above. Staining was not observed when the primary
antibody was omitted.
IMMUNOFLUORESCENCE AND CONFOCAL MICROSCOPY
For double-labeling experiments, free-floating sections were pro-
cessed according to the P-STAT3 protocol until the incuba-
tion with the primary antibody. Then they were incubated
overnight in a mixture of two primary antibodies: polyclonal
goat anti-CNTF (1:50) and monoclonal mouse anti-GFAP anti-
body (1:1000); polyclonal goat anti-CNTF (1:50) and poly-
clonal rabbit anti-P-STAT3 (1:700) or polyclonal rabbit anti-
P-STAT3 (1:700) and mouse monoclonal anti HuC/D (1:100).
The next day sections were washed twice with PBS and incu-
bated in a cocktail of fluorophore-linked secondary antibodies
at a dilution of 1:100 in PBS for 1 h at room temperature. The
secondary antibodies were DyLight™488-conjugated anti-goat
IgG, DyLight™549-conjugated anti-mouse IgG, DyLight™488-
conjugated anti-rabbit IgG and DyLight™649-conjugated anti-
rabbit IgG (all from Jackson ImmunoResearch, West Grove,
PA, USA). Sections were subsequently washed twice with PBS,
mounted on standard glass slides, air-dried and coverslipped
using Vectashield mounting medium (Vector). Sections were
viewed under a motorized Leica DM6000 microscope at different
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magnifications. Fluorescence was detected with a Leica TCS-
SL spectral confocal microscope (Leica Microsystems) equipped
with an Argon and He/Ne mixed gas laser. Fluorophores were
excited with the 488, 543, and 649 nm lines and imaged sepa-
rately. Images (1024 × 1024 pixels) were obtained sequentially
from two channels using a confocal pinhole of 1.1200 and
stored as TIFF files. Brightness and contrast of the final images
were adjusted using Photoshop 6 (Adobe Systems, Mountain
View, CA, USA). The percentages of GFAP-positive tanycytes
and astrocytes also expressing CNTF and the percentage of
GFAP-positive tanycytes also expressing P-STAT3 were calcu-
lated in 5 alternate double-stained coronal sections of the tuberal
portion of the hypothalamus from 5 mice per experimental
group.
STATISTICAL ANALYSIS
Differences between groups were evaluated by One-Way ANOVA.
Statistical analysis was performed with GraphPad Prism (version
5.00 for Windows) software (San Diego, CA, USA). A level of
p < 0.05 was considered significant.
RESULTS
CNTF-PRODUCING CELLS IN THE HYPOTHALAMUS OF HFD MICE
After 12 weeks on the HFD mice weighed significantly more
than controls (Figure 1A). The hypothalamic expression of NPY
mRNA (Figure 1B) and POMC mRNA (Figure 1C), the latter
coding for the anorexigenic peptide α-MSH, was higher in HFD
mice than in control animals, but the increase was not statisti-
cally significant. CNTF mRNA was significantly increased in the
hypothalamus of HFD mice and was almost double that seen in
controls (Figure 2A). The increase appeared to be restricted to the
hypothalamus, because no differences in CNTF expression were
found in the samples containing the remaining brain portions
(data not shown). Western blot analysis of hypothalamic protein
extracts confirmed that CNTF expression was higher in HFD than
in control mouse hypothalamus, although the difference was not
significant due to a high interindividual variability among HFD
mice (Figure 2B).
CNTF was detected by immunohistochemistry in the ependy-
mal cells and tanycytes of the third ventricle wall and in
subependymal astrocytes in the hypothalamus of both control
(Severi et al., 2012) andHFDmice. Comparison of corresponding
coronal brain sections, processed in the same immunohistochem-
ical experiment under standardized conditions, disclosed that
while similar levels of CNTF staining were found in the preop-
tic and anterior hypothalamus of HFD and control mice, CNTF
staining was stronger in the tuberal and mammillary regions of
HFD mice. In particular, intensely stained tanycytes lining the
ventrolateral walls of the third ventricle were detected in the
ependymal layer of the tuberal region of the hypothalamus of
HFD mice (compare Figure 3B with Figure 3A and Figure 4D
with Figure 4A); sometimes their long projections into the under-
lying gray matter were also variably stained (inset of Figure 3B).
Additionally, astrocytes located in the arcuate nucleus were more
intensely stained in HFD than in control mice. Double-staining
experiments and morphometry disclosed that the percentage
of GFAP-positive tanycytes that were also positive for CNTF
FIGURE 1 | (A) trends of the body weight of mice fed an HFD diet, a
low-fat diet (Ctrl), or a CR regimen for 12 weeks. RT-PCR analysis of NPY
(B) and POMC (C) expression in the hypothalamus of HFD, control (Ctrl)
and CR mice. Mean ± SEM. ∗P < 0.05.
FIGURE 2 | RT-PCR (A and C) and Western blot (B and D) analyses of
CNTF (A and B) and CNTFRα (C and D) expression in the
hypothalamus of HFD, control (Ctrl) and CR mice. For Western blots the
densitometric analysis was normalized to β-tubulin expression. In (B)
recombinant CNTF (P, 30 ng) loaded together with hypothalamic protein
extracts served as a positive control. Mean ± SEM. ∗P < 0.05.
increased significantly in HFD mice (Figure 5A), whereas the
number of astrocytes also expressing CNTF did not change (data
not shown). Collectively, these data document that HFD induces
an increased CNTF expression that is especially evident in the
tanycytes of the tuberal and mammillary regions.
CNTF-RESPONSIVE CELLS IN THE HYPOTHALAMUS OF HFD MICE
In order to gain further insights into the role played by CNTF
in the hypothalamus of mice fed an HFD we evaluated the
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FIGURE 3 | Immunohistochemical detection of CNTF in the mouse
tuberal hypothalamus. Some CNTF-stained tanycytes on the
ventrolateral wall of the third ventricle (3V) in control mouse (A). In
an HFD mouse (B), strongly increased CNTF staining of tanycytes
also results in more (inset of B, arrow) or less (inset of B,
arrowheads) intense staining of their long projections. In contrast,
tanycytes in CR mice (C) exhibit very low-level staining. The insets of
(A,B) are the enlargements of the corresponding framed areas. ME,
median eminence. Bar: (A–C) 400μm; inset of (A) 40μm; inset of
(B) 300μm.
FIGURE 4 | CNTF/P-STAT3 double-labeling of coronal sections of the
tuberal hypothalamus from CNTF-treated control (A–C), HFD (D–F) and
CR (G–I) mice. Compared with controls (A,B) the greater CNTF expression
seen in tanycytes of HFD mice (D) is matched by increased CNTF
responsiveness (E). In CRmice both CNTF expression (G) and responsiveness
(H) are lower than in control mice and, especially, HFD mice. Bar: 100μm.
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FIGURE 5 | Percentage of CNTF-producing (A) and CNTF-responsive (B)
tuberal and mammillary tanycytes in HFD, control (Ctrl) and CR mice.
Morphometric evaluation performed by confocal microscopy in
double-stained sections where tanycytes were labeled by GFAP and CNTF
responsiveness was evaluated by P-STAT3 immunohistochemistry in
CNTF-treated mice. Mean ± SEM. ∗P < 0.05.
expression of its specific receptor, CNTFRα. A significant increase
of CNTFRα mRNA was found in the hypothalamus of HFD
mice compared with controls (Figure 2C), whereas no differ-
ences in CNTFRα mRNA levels were detected in the extracts
of the remaining brain portions (data not shown). In con-
trast to RT-PCR data, Western blotting showed no difference
in CNTFRα protein content between HFD and control mice
(Figure 2D).
Intraperitoneally or intravenously injected CNTF rapidly
reaches distinctive areas of the brain parenchyma by cross-
ing the blood-cerebrospinal fluid barrier and the blood-brain
barrier (Poduslo and Curran, 1996; Pan et al., 1999; Lambert
et al., 2001). As a consequence, detection of nuclear P-STAT3
immunoreactivity after systemic CNTF treatment is a reliable
neuroanatomical tool to obtain a functional mapping of the
central actions of CNTF and to characterize CNTF-responsive,
CNTFRα-bearing cells (MacLennan et al., 2000). Similar to con-
trol mice (Severi et al., 2012), P-STAT3 immunoreactivity was
detected in arcuate nucleus neurons, ependymal cells and tany-
cytes of CNTF-treated HFD mice. Very few astrocytes were
activated. Ependymal STAT3 signaling following CNTF injec-
tion was stronger in the tuberal and mammillary regions of
HFD than in control mice (compare Figure 4E with Figure 4B,
Figure 4Fwith Figure 4C and Figure 6Bwith Figure 6A). Indeed,
the percentage of tanycytes also responding to exogenously
administered CNTF was significantly higher in HFD than con-
trol mice (Figure 5B). Most importantly, CNTF administra-
tion to HFD obese mice induced STAT3 activation in a large
population of adjacent cells in the gray matter of the tuberal
and mammillary regions of the hypothalamus (Figure 6B). These
CNTF-responding cells, showing specific nuclear P-STAT3 stain-
ing, were characterized by round nuclei with a frequently
unstained nucleolus whose profile resembled that of neurons
(Figure 6D). P-STAT3-positive cell projections were also noted
among positive cells (Figure 6D, arrowheads). All these cells
were also positive for the neuronal marker HuC/D (Figure 6E),
which confirmed that they were indeed neurons. Confocal
microscopy examination also allowed identification of P-STAT3-
positive projections as neuronal projections. Nissl staining of
adjacent brain sections demonstrated that CNTF-responsive neu-
rons were located in the ventromedial (VMH) and dorsomedial
(DM) nuclei, perifornical area and gray matter of the mam-
millary body. Consequently, the higher CNTF expression seen
in the ependyma of the tuberal and mammillary regions of the
HFD mouse hypothalamus is matched by an increased CNTF
responsiveness. In particular, exogenously administered CNTF
elicited a response from HFD mouse neurons that were never
activated in control mice. On the whole, these data suggest
that CNTF signaling increases in the hypothalamus of HFD
mice.
CNTF SIGNALING IN THE HYPOTHALAMUS OF CR MICE
If an HFD induces increased hypothalamic CNTF signaling, CR
is expected to exert the opposite effect. After 12 weeks, the body
weight of CR mice was significantly lower than that of control
mice (Figure 1A). Similar to fasted mice (Mizuno et al., 1999),
CR mice exhibited significantly higher mRNA levels of the orexi-
genic peptide NPY (Figure 1B) and non-significantly lower levels
of the anorexigenic POMC peptide compared with control ani-
mals (Figure 1C). Hypothalamic CNTF mRNA levels were lower
in CR mice than in control mice and HFD mice, but the differ-
ence was significant only in the latter animals (Figure 2A). In
addition, CNTFRα mRNA decreased significantly in CR com-
pared with control and HFD mice (Figure 2C), whereas CNTF
and CNTFRα levels showed no differences in samples contain-
ing the remaining parts of the brain (data not shown). Western
blot analysis showed a reduction of both CNTF (Figure 2B)
and CNTFRα (Figure 2D) in the hypothalamus of CR mice,
but here too the high SEM involved that the difference was not
significant.
As in controls, CNTF was detected by immunohistochem-
istry in hypothalamic ependymal cells, tanycytes and astro-
cytes. Comparison of corresponding sections revealed that
ependymal CNTF staining in the tuberal and mammillary
parts of the hypothalamus was lower in CR than in con-
trol mice (compare Figure 3C with Figure 3A and Figure 4G
with Figure 4A). Accordingly, the number of tanycytes also
expressing CNTF showed a significant reduction (Figure 5A).
CNTF administration induced a weaker activation of STAT3
signaling in the ependymal wall and arcuate nucleus (com-
pare Figure 4H with Figure 4B, Figure 4I with Figure 4C and
Figure 6C with Figure 6A) and the number of P-STAT3-positive
tanycytes significantly reduced (Figure 5B). P-STAT3-positive
neurons were never observed outside the arcuate nucleus in these
mice.
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FIGURE 6 | P-STAT3 immunohistochemistry in the tuberal region of
CNTF-treated mice. In a control mouse (A), P-STAT3 staining depicts
ependymal cells (ep) and neurons located in the arcuate nucleus (Arc)
and median eminence (ME). In an HFD mouse (B), P-STAT3
immunoreactivity increases at these sites, but responsiveness to CNTF
is also detectable in the dorsomedial hypothalamus (DM) and, to a
lesser extent, the ventromedial nucleus (VMH). CNTF responsiveness is
blunted in a CR mouse (C). The inset of (C) shows a representative
Nissl-stained coronal section of the tuberal region of the hypothalamus.
(D) is the enlargement of the area framed in (B), where P-STAT3
immunoreactivity is found not only in cell nuclei but also in varicose
projections (arrowheads). In (E), double-staining immunofluorescence and
confocal microscopy show that in the DM of a CNTF-treated HFD
mouse P-STAT3-positive cell nuclei are contained in HuC/D-positive
neuronal cell bodies. 3V, third ventricle; v, blood vessel. Bar: (A–C)
100μm; (D) 20μm; (E) 15μm; inset of (C) 400μm.
CNTF SIGNALING IN THE HYPOTHALAMUS OF ob/ob MICE
Besides HFD mice, which are the experimental model most sim-
ilar to human obesity, another widely employed experimental
model of obesity is ob/ob mice, where genetic leptin deficiency
induces severe obesity as well as a number of other metabolic
and endocrine abnormalities, such as hypothyroidism and hypog-
onadism. Examination of the indices of CNTF signaling dis-
closed the absence of any changes in CNTF or CNTFRα mRNA
(Figure 7) or protein expression in the hypothalamus of ob/ob
vs. wild type lean mice. By immunohistochemistry, CNTF was
expressed by hypothalamic ependyma (including tanycytes) and
astrocytes, without differences between ob/ob and wild type mice
(data not shown). Finally, CNTF administration in these mice
activated ependymal cells, tanycytes and arcuate nucleus neu-
rons, but never the neuron populations that were found to be
CNTF-responsive in HFD obese mice.
DISCUSSION
The widespread occurrence of obesity and associated diseases
requires urgent investigation of the central mechanisms involved
in energy balance regulation. The tuberal region of the hypotha-
lamus, containing the arcuate nucleus, VMH, DM and the lateral
hypothalamic area, is a prominent brain region for the integra-
tion of metabolically relevant stimuli (Williams and Elmquist,
2012). The arcuate nucleus, lying adjacent to the bottom of the
third ventricle and to the median eminence, is a circumventricu-
lar organ lacking the blood-brain barrier that is ideally located
to sense metabolically relevant molecules in the circulation. It
contains peptidergic neurons that respond to acute and long-
term metabolic inputs in opposite ways: NPY neurons strongly
stimulate food intake whereas POMC neurons, by cleaving the
POMC gene product into α-MSH, induce a strong reduction in
food intake and increase energy expenditure. Arcuate nucleus
neurons massively project to the paraventricular nucleus, VMH,
DM and the lateral hypothalamic area, where additional second-
order peptidergic neuronal systems participate in energy balance
control (Schwartz et al., 2000; Sohn et al., 2013).
We previously showed that CNTF is expressed in the
ependyma of the third ventricle and in astrocytes of the normal
mouse hypothalamus (Severi et al., 2012). Here we show that
CNTF expression significantly increases in the ependymal layer
of the tuberal and mammillary regions of mice rendered obese
by an HFD and that it significantly decreases in mice kept in CR
conditions. Interestingly, changes in CNTF expression were par-
alleled by changes in its specific receptor, CNTFRα; as a result
hypothalamic responsiveness to CNTF was greater in HFD than
in CR mice. Collectively, these data suggest that in mice an HFD
is associated with increased CNTF signaling in the hypothalamus,
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FIGURE 7 | RT-PCR analysis of CNTF (A) and CNTFRα (B) in the
hypothalamus of wild type (wt), ob/+ and ob/ob mice. Mean ± SEM.
whereas CR is associated with reduced hypothalamic CNTF sig-
naling. Even though the metabolically relevant stimuli (nutrients
and/or hormones) that are capable to induce such changes in
CNTF signaling are still unclear, the present findings support
the notion that CNTF is a novel, glial-derived modulator of the
energy balance. By acting at the central level, administration of
CNTF or Axokine reduces food intake (Gloaguen et al., 1997;
Lambert et al., 2001; Sleeman et al., 2003; Blüher et al., 2004) and
increases energy expenditure (Solymár et al., 2011). Thus, upreg-
ulation of CNTF signaling in the hypothalamus of HFD mice
may be viewed as a compensatory mechanism counteracting the
positive energy balance.
In this study we used HFD mice because they are consid-
ered as the most representative model of human obesity. Indeed,
the modern human diet is rich in saturated fat, especially in
Western countries, and mice fed an HFD for a prolonged period
develop an obesity syndrome showing all the hallmarks of human
obesity, such as leptin resistance, impaired glucose tolerance,
dyslipidaemia, hypertension, hepatic steatosis and adipose tissue
inflammation (Panchal and Brown, 2011; Giordano et al., 2013).
In contrast, ob/ob mice show severe hyperphagic obesity due
to the genetic absence of the satiety factor leptin. Interestingly,
unlike their HFD obese counterparts these mice showed no evi-
dence of increased hypothalamic CNTF signaling. This suggests
that leptin does not affect hypothalamic CNTF signaling and
also that diet composition may affect CNTF expression and
signaling to a greater degree than food amount in the mouse
hypothalamus.
The lack of change in the expression of CNTF and CNTFRα
seen in ob/ob mice is also in line with the ability of CNTF
to reduce food intake in these animals (Lambert et al., 2001).
On the other hand, CNTFRα deletion in hypothalamic leptin
receptor-expressing neurons does not impair the anorectic effect
of Axokine (Stefater et al., 2012). Collectively, these data provide
further support for the fact that the hypothalamic effects of
CNTF on the energy balance are independent of leptin signaling.
Thus, a greater knowledge of CNTF-mediated regulation of the
energy balance may suggest new therapeutic strategies for human
leptin-resistant obesity.
That endogenous CNTF could have a role as a modulator
of the energy balance in the hypothalamus was first surmised
by Vacher et al. (2008), who also found CNTF upregulation
in the hypothalamus of rats rendered obese by a high-sucrose
diet and ascribed it to neurons and astrocytes in the arcu-
ate nucleus (Vacher et al., 2008). Even though we detected
CNTF immunoreactivity in mouse arcuate nucleus astrocytes,
we found no CNTF-positive neurons in this nucleus or in
any other region of the mouse hypothalamus. Thus, CNTF
production by hypothalamic neurons remains to be demon-
strated. However, our immunohistochemical data agree with
findings obtained in other CNS regions, where CNTF is a
glial-derived neurotrophic factor, at least in normal conditions
(Sleeman et al., 2000).
Indeed, in situ hybridization and immunohistochemistry have
documented that mouse CNTF expression is confined to glial
cells in the brain, including astrocytes and ependymal layer
cells (Guthrie et al., 1997; Dallner et al., 2002; Severi et al.,
2012). We demonstrated CNTF upregulation in HFD mice,
mainly in tanycytes of the tuberal and mammillary regions of
the hypothalamus. In addition, tanycytes and ependymal cells at
these sites were also more responsive to CNTF, as reflected by
the stronger P-STAT3 expression found in CNTF-treated obese
mice. The close spatial relationship of CNTF-producing and
CNTF-responding cells suggests that a local, CNTF-dependent,
autocrine-paracrine circuit may be recruited in situations of
positive energy balance. The opposite mechanism is likely to
be activated in conditions of chronic negative energy balance
(CR mice).
Hypothalamic tanycytes are a heterogeneous population of
glial cells that constitute the main cell type in the ependymal layer
of the tuberal andmammillary regions of the hypothalamus. They
are characterized by a cell body located in the ependymal layer
and by a single process branching into the underlying neuropil.
Recently it has been suggested that third ventricle tanycytes, by
affecting neurogenesis, may have a role in the neural control of the
energy balance (Bolborea and Dale, 2013). Neurogenesis occurs
in the adult hypothalamus and contributes to the plasticity and
remodeling of the hypothalamic neuronal networks involved in
the control of feeding and energy expenditure (Kokoeva et al.,
2005; Xu et al., 2005; Perez-Martin et al., 2010; Pierce and Xu,
2010; Lee et al., 2012). Although the identity and location of adult
hypothalamic stem/progenitor cells is yet to be clarified, recent
studies suggest that neurogenic niche-like structures may be
found along the third ventricle wall (Xu et al., 2005; Migaud et al.,
2010; Lee et al., 2012), where tanycytes are good candidates for the
role of stem/progenitor cells. In particular, tanycytes are remnants
of the radial glial cells that during development serve as neural
progenitors and form a scaffold for the migration of newly gener-
ated neurons (Kriegstein and Alvarez-Buylla, 2009). In themature
brain they retain the expression of neural stem cell markers such
as nestin, vimentin and doublecortin-like proteins (Rodríguez
et al., 2005; Saaltink et al., 2012). They also express Notch pathway
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components and hypothalamic progenitor-specific transcription
factors (Shimogori et al., 2010). Fate mapping experiments using
BrdU showed that tanycytes can proliferate in response to basic
fibroblast growth factor (b-FGF; Xu et al., 2005) and insulin-
like growth factor I (Perez-Martin et al., 2010). Finally, genetic
fate mapping studies showed that a subset of median eminence
tanycytes can generate neurons in newborns (Lee et al., 2012);
in addition, the proliferation properties of a subpopulation of α-
tanycytes has been shown to depend on FGF signaling (Robins
et al., 2013). Our findings, showing that tanycytes are responsive
to CNTF, suggest that the enhanced hypothalamic neurogene-
sis linked to intracerebroventricular infusion of CNTF (Kokoeva
et al., 2005) relies on the action of exogenous CNTF on tuberal
and mammillary region tanycytes. On the other hand, our data
show that tanycytes do not only respond to CNTF but also pro-
duce it, especially in the HFD condition. Notably, upregulation
of median eminence neurogenesis has been shown to occur in
response to HFD in mice (Lee et al., 2012). Thus, the increased
CNTF signaling detected in tanycytes located close to the median
eminence in our HFD obese mice lends support to the hypothesis
that CNTF signaling is a molecular pathway recruited by the HFD
to enhance neurogenesis in the hypothalamus.
A distinctive finding of our study was that a large popu-
lation of neurons located outside the arcuate nucleus, specifi-
cally in DM, VMH, the perifornical area and mammillary body,
develop responsiveness to CNTF inHFDmice. Importantly, when
hypothalamic CNTF signaling did not change, as in ob/ob obese
mice, or decreased, as in CR mice, these neurons did not respond
to CNTF. Further investigation is required to characterize the
phenotype of these neurons and find whether CNTF activates
or inhibits them. However our data highlight novel and spe-
cific targets of CNTF, or Axokine, in the brain of HFD mice. An
interesting question arising from these findings is the putative
endogenous source of CNTF that can affect this neuronal pop-
ulation in the HFD condition. The present data point to tanycytes
as the major CNTF-producing cell type in the tuberal and mam-
millary hypothalamus. Tanycytes are provided with a single basal
process that ramifies into the underlying neuropil, contacting
neurons and glial cells and/or ending on capillaries (Rodríguez
et al., 2005). Osmophilic inclusions and numerous polymorphic
and round vesicles have been described by transmission electron
microscopy within the endfeet of tanycytes, suggesting a possi-
ble secretory role for them (Monroe and Paull, 1974). Thus, the
CNTF upregulation seen in HFD mouse tanycytes and, notably,
their stained processes, may be morphological features reflect-
ing an increased synthesis and secretion of CNTF, which in turn
diffuses by volume transmission in the neuropil and reaches
distant neurons. However, the considerable mismatch between
the putative site of CNTF production and secretion (tanycytes)
and its putative central targets (likely the second-order neurons
of the energy balance circuits) suggests the interesting possibil-
ity that CNTF may be a circulating factor capable to affect the
hypothalamic neuronal circuits of the energy balance in HFD
conditions.
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